TNFRSF1B and TNF Variants Are Associated With Differences in Levels of Soluble Tumor Necrosis Factor Receptors in Patients With Severe COVID-19.
Ingrid Fricke-GalindoIvette Buendía-RoldánAndy RuizYadira PalaciosGloria Pérez-RubioRafael de Jesus Hernández-ZentenoFelipe Reyes-MelendresArmando Zazueta-MárquezAimé Alarcón-DionetJavier Guzmán-VargasOmar Andrés Bravo-GutiérrezTeresa Quintero-PuertaIlse Adriana Gutiérrez-PérezKarol J Nava-QuirozJosé Luis Bañuelos-FloresMayra MejíaJorge Rojas-SerranoEspiridión Ramos-MartínezIris Paola Guzmán-GuzmánLeslie Chávez-GalánRamcés Falfan-ValenciaPublished in: The Journal of infectious diseases (2022)
Genetic variants in TNF and TNFRSFB1 influence the plasma levels of soluble TNFR1 and TNFR2, implicated in COVID-19 severity.